2/26/2025 Gina S Sold and shipped by Sabaforlife.com Im loving Saba GLP-1
The incidence of depression or self-harm was 8.2 vs 11.7 events/1,000 person-years in the DPP-4i-cohort and 18.2 vs 13.6 events/1,000 person-years in the GLP-1 RA cohort for incretin-based therapies vs sulfonylureas, respectively
"Because regardless of whether they want to go to Ro or they want to go to their in-person doctor, you want to better understand what their options are."
Mehrpour has authored over 250 peer-reviewed publications and is ranked among the top 2% of scientists worldwide
Newsome PN, Buchholtz K, Cusi K, et al
6,7 "Novo Nordisk is pleased to offer a new treatment that can provide some patients who have obesity or are overweight with comorbidities a new path to achieving clinically meaningful weight loss," said Jesper Hoiland, President of Novo Nordisk Inc